-
Ariyoshi K, Matsuda M, Miura H, Tateishi S, Yamada K, Sugiura W, 2003: Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtypeE) infection differ from subtype B infection[J]. J Acquir Immune Defic Syndr, 33, 336-342. doi: 10.1097/00126334-200307010-00007
-
Li H, Geng Q, Guo W, Zhuang D, Li L, Liu Y, Bao Z, Liu S, Li J, 2012: Screening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in China[J]. PLoS One, 7, e47119-. doi: 10.1371/journal.pone.0047119
-
Li X P, Xing H, Wang Z, Si X F, Wang L E, Cheng H, Cui W G, Jiang S L, Liao L J, Zhou H W, Huang J H, Peng H, Ma P F, Shao Y M, 2007: Study of HIV-1 drug resistance in patients receiving free antiretroviral therapy in China[J]. Virol Sin, 22, 233-240. doi: 10.1007/s12250-007-0027-y
-
Li Z, Huang Y, Ouyang Y, Xing H, Liao L, Jiang S, Shao Y, Ma L, 2013: Mutation covariation of HIV-1 CRF07_BC reverse transcriptase during antiretroviral therapy[J]. J Antimicrob Chemother, 68, 2521-2524. doi: 10.1093/jac/dkt228
-
Liao L, Xing H, Li X, Ruan Y, Zhang Y, Qin G, Shao Y, 2007: Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China[J]. AIDS Res Hum Retroviruses, 23, 1062-1065. doi: 10.1089/aid.2007.0050
-
Pereira C F, Paridaen J T, 2004: Anti-HIV drug development--an overview[J]. Curr Pharm Des, 10, 4005-4037. doi: 10.2174/1381612043382459
-
Reuman E C, Rhee S Y, Holmes S P, Shafer R W, 2010: Constrained patterns of covariation and clustering of HIV-1non-nucleoside reverse transcriptase inhibitor resistance mutations[J]. J Antimicrob Chemother, 65, 1477-1485. doi: 10.1093/jac/dkq140
-
Richman D D, Morton S C, Wrin T, Hellmann N, Berry S, ShapiroM F, Bozzette S A, 2004: The prevalence of antiretroviral drug resistance in the United States[J]. AIDS, 18, 1393-1401. doi: 10.1097/01.aids.0000131310.52526.c7
-
Tee K K, Pybus O G, Li X J, Han X, Shang H, Kamarulzaman A, Takebe Y, 2008: Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia[J]. J Virol, 82, 9206-9215. doi: 10.1128/JVI.00399-08
-
Wu H, Zhang H J, Zhang X M, Xu H F, Wang M, Huang J D, Zheng B J, 2012: Identification of drug resistant mutations in HIV-1 CRF07_BC variants selected by nevirapine in vitro[J]. PLoS One, 7, e44333-. doi: 10.1371/journal.pone.0044333
-
Xiao L, Wu Z, Luo W, Wei X, 2010: Quality of life of outpatientsin methadone maintenance treatment clinics[J]. J Acquir Immune Defic Syndr, 53, S116-120.
-
Yu G, Li Y, Li J, Diao L, Yan X, Lin P, He Q, Wang Y, Fu X, YangF , Long Q, 2009: Genetic diversity and drug resistance of HIV type 1 circulating recombinant Form_BC among drug users in Guangdong Province[J]. AIDS Res Hum Retroviruses, 25, 869-875. doi: 10.1089/aid.2008.0312
-
Yuan D F L, Xi J, 2011: Moleculo-epidemiological study of HIV-1/AIDS among 77 men having sex with men in Sichuan province[J]. Chinese J STD/AIDS Prev Cont, 17, 410-413.
-
Zeng P L Y, 2013: HIV-1 genotypic diversity and prevalence of drug resistance among treatment naive HIV-infected individuals in Chengdu of China[J]. Virus Genes, 47, 6-.